Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.
Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Cell Death Differ. 2018 Jan;25(1):93-103. doi: 10.1038/cdd.2017.171. Epub 2017 Nov 3.
The transcription factor p53 is a vital tumor suppressor. Upon activation by diverse stresses including oncogene activation, DNA damage, hypoxia and nutrient deprivation, p53 activates a panoply of target genes and orchestrates numerous downstream responses that suppress tumorigenesis. Although early studies of p53 suggested that its ability to induce cell cycle arrest, senescence and apoptosis programs accounted for its tumor-suppressor activity, more recent studies have challenged this notion. Moreover, p53 regulates a suite of additional processes, such as metabolism, stem cell function, invasion and metastasis. The processes p53 coordinately regulates to enact tumor suppression, and how such regulation occurs, thus remain elusive. In this review, we will summarize our current knowledge of p53-mediated tumor-suppressive mechanisms gleaned from in vivo studies in mouse models.
转录因子 p53 是一种重要的肿瘤抑制因子。p53 受到多种应激的激活,包括癌基因激活、DNA 损伤、缺氧和营养剥夺等,它会激活一系列靶基因,并协调众多下游反应,抑制肿瘤发生。尽管早期对 p53 的研究表明,它诱导细胞周期停滞、衰老和凋亡程序的能力解释了其肿瘤抑制活性,但最近的研究对这一观点提出了挑战。此外,p53 还调节了一系列其他过程,如代谢、干细胞功能、侵袭和转移。p53 协同调节以实施肿瘤抑制,以及这种调节是如何发生的,因此仍然难以捉摸。在这篇综述中,我们将总结从小鼠模型的体内研究中获得的关于 p53 介导的肿瘤抑制机制的现有知识。